Your browser doesn't support javascript.
loading
Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report.
Nelson, Blessie Elizabeth; Hong, Angelina; Dekmezian, Mhair; Jana, Bagi.
Afiliación
  • Nelson BE; Department of Hematology & Oncology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Hong A; School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • Dekmezian M; School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • Jana B; Department of Pathology, Mainland Medical Center, Texas City, Texas, USA.
Case Rep Oncol ; 14(2): 1066-1070, 2021.
Article en En | MEDLINE | ID: mdl-34326743
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving uncontrolled inflammation due to widespread activation of immune response. HLH can be inherited or acquired secondary to infection, autoimmune, or oncologic processes such as small lymphocytic lymphoma (SLL) or chronic lymphocytic leukemia (CLL). There has been minimal documentation of HLH secondary to SLL/CLL, and results of treatment have been largely unsuccessful. This case describes a critically ill elderly patient with HLH caused by SLL/CLL who was successfully treated with standard-dose rituximab and regained a high quality of life.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Case Rep Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Case Rep Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza